MD+DI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Your Chance for MDEA Gold

MDEA_Main_4c_web.jpg
Submit your medical device innovations to the 2022 Medical Design Excellence Awards competition by January 12, 2022.

The Medical Design Excellence Awards (MDEAs) is now accepting entries through January 12 for the 2022 competition, with early-bird pricing of $149 available through December 8, 2021. Full price entries are $199.

Since 1998, the MDEAs have recognized significant achievements in medical product design and engineering that improve the quality of healthcare delivery and accessibility. In the 2021 competition, for instance, Medtronic’s LINQ II Insertable Cardiac Monitoring (ICM) System won Best-in-Show, while its CareLink SmartSync Device Manager earned the MD+DI Readers’ Choice award. 

Entries are accepted in 11 product categories:

  • Cardiovascular Devices—devices and equipment used to diagnose or treat conditions of the heart and circulatory system
  • Digital Health Products and Mobile Medical Apps—devices or applications that use digital technologies to monitor patients, deliver healthcare, or make medicine more personalized
  • Drug-Delivery and Combination Products—devices such as pre-filled syringes, misting devices, dry powder inhalers, patches, pouches, or combination implants with biologic agents, etc.
  • ER and OR Tools, Equipment, and Supplies—devices such as critical care, general surgery, plastic surgery, and anesthesiology products
  • Gastrointestinal and Genitourinary Devices—products such as gastrological, urological, gynecological, and obstetric devices
  • Implant and Tissue-Replacement Products—devices such as cochlear, corneal, orthopedic, neurological, and tissue implants and instruments
  • Nonsurgical Hospital Supplies and Equipment—products such as general medical equipment and supplies used in hospitals and doctor's offices, such as stethoscopes, blood lancets, medical carts, ventilators, hospital beds, blood pressure monitors, etc.
  • Over the Counter and Self-Care Devices—devices that can be purchased without a prescription or that allow patients to monitor, treat, or help prevent a health condition without assistance from a clinician or other healthcare professional
  • Radiological, Imaging, and Electromechanical Devices—devices that use medical radiation, imaging, or an electromechanically powered system to diagnose or treat diseases
  • Rehabilitation and Assistive-Technology Products—products such as wheelchairs, walkers, crutches, hearing aids, prosthetic devices, etc.
  • Testing and Diagnostic Products and Systems—products that fall into FDA categories of chemistry, hematology, immunology, microbiology, pathology, and toxicology

Entries are scored based on five criteria:

  • Design and engineering Innovations
  • Functional (user-related) innovations
  • Benefits to overall healthcare
  • Benefits to patients
  • Differentiation in the market

An independent panel of esteemed jurors — made up of clinicians, engineers, and designers — select up to six finalists, as well as Bronze, Silver, and Gold winners in each of the 11 product categories, along with overall Best-in-Show winner. The award ceremony will be held at MD&M West, set to take place April 12-14 at the Anaheim Convention Center; all entrants in the 2022 MDEAs will receive a 20 percent discount on 2022 MD&M West conference registration. Bronze, Silver, and Gold MDEA winners will get one free two-day MD&M West conference pass.

The MDEA program accepts entries worldwide from companies and individuals involved in the design, engineering, manufacture, or distribution of finished medical devices. The competition is open to finished medical devices, including instruments, machines, implants, in vitro reagents, mobile medical applications, or other related products that are intended for the diagnosis, cure, mitigation, treatment, or prevention of disease or other conditions in humans or animals. Product components by themselves are not eligible except in the case of the Drug-Delivery and Combination Products category, in which finished stock drug-delivery devices may be entered prior to receiving regulatory clearance or approval. Participants gain worldwide recognition for their company and build buzz for their medtech product, and MDEA finalists and winners are granted exclusive use of the MDEA logo to promote their product and benefit from editorial coverage on MD+DI and in MDEA marketing.

Entries can be submitted by the product’s manufacturer of record or by suppliers that provide materials, components, or services with the manufacturer's written consent. To be eligible for entry in the 2022 MDEA competition, products must be commercially available (able to be ordered or purchased in at least one country) by December 31, 2021.

To learn more about the MDEA program and enter today to enjoy Early-Bird Pricing, visit www.mdeawards.com. The medical device industry’s premier awards program organized by Informa Markets – Engineering, publisher of MD+DI.

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish